Zohar Ben-Shatach

2PUBLICATIONS
4CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jun 01, 2022
Delaying an infliximab infusion by more than 3 days is associated with a significant reduction in trough levels but not with clinical worsening.

Zohar Ben-Shatach, Tomer Ziv-Baran, Ella Fudim

|Apr 10, 2021
Dose optimisation for Loss of Response to Vedolizumab- Pharmacokinetics and Immune Mechanisms.

Bella Ungar, Karin Malickova, Jurij Hanžel

Pageof 1